% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, AŞ Message Board

  • cigan1956 cigan1956 Jul 8, 2013 10:09 AM Flag

    The Patent Expiration Of Dacogen Is Now A Non Issue. No Generic Mfg Will Compete Against The New Standard Of Care.

    The oral delivery of a low dose for sustained circulation in the body. "Relevant animal studies revealed that the product can result in therapeutic exposures of decitabine at low doses. The profile of E7727 is
    expected to result in low inter-patient variability across doses of decitabine
    with little or no gastrointestinal safety issues."

    SortNewest  |  Oldest  |  Most Replied Expand all replies